Literature DB >> 16133063

Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome.

Afig Berdeli1, Sevgi Mir, Nese Ozkayin, Erkin Serdaroglu, Yilmaz Tabel, Alphan Cura.   

Abstract

The potential effects of macrophage migration inhibitory factor (MIF) on the natural immune response are due to the inhibition of immune cell activation, which is regulated by glucocorticoids. In this study, we investigated MIF -173G/C genotype and C allele frequency in 214 patients with idiopathic nephrotic syndrome (INS) and 103 healthy volunteers. We found significant increases in GC genotype (OR=3, p=0.0009) and C allele frequency (OR=2.5, p=0.0007) in INS. Upon classifying patients as steroid responsive (n=137) or resistant (n=77), a 20-fold over-expression of the CC-genotype was found in the steroid-resistant group (OR=20, p=0.0002). Moreover, a significant increase in C allele frequency in patients with focal segmental glomerulosclerosis (FSGS) has also been noted when compared with other histopathological groups (OR=3.2, p=0.0017). Furthermore, significant increases in the CC genotype (15.6% vs 3.3%) and C allele (75% vs 32%) frequencies have been found in patients with permanent renal function failure (p=0.013 and p=0.0002, respectively). Patients with the CC genotype were found to be at considerably increased risk of permanent renal failure (OR=5.43, p=0.013) and end-stage renal disease (OR=5.53, p=0.020). Additionally, there was a correlation between age of detection of proteinuria and CC genotype. We found an earlier age of onset of proteinuria in patients with the CC genotype (1.9+/-1.7 years) than in patients who were GC-heterozygous (3.7+/-3.1 years) and GG-homozygous (3.6+/-2.9 years, p=0.88). In summary, our results indicate that the MIF -173 C allele confers an increased risk of susceptibility to INS and plays a crucial role in glucocorticoid responsiveness.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133063     DOI: 10.1007/s00467-005-1930-9

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  31 in total

1.  Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo.

Authors:  Gunter Fingerle-Rowson; Peter Koch; Rachel Bikoff; Xinchun Lin; Christine N Metz; Firdaus S Dhabhar; Andreas Meinhardt; Richard Bucala
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 2.  Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery.

Authors:  E Lolis
Journal:  Curr Opin Pharmacol       Date:  2001-12       Impact factor: 5.547

3.  Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids.

Authors:  L Santos; P Hall; C Metz; R Bucala; E F Morand
Journal:  Clin Exp Immunol       Date:  2001-02       Impact factor: 4.330

4.  Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrophage migration inhibitory factor.

Authors:  A V Sampey; P H Hall; R A Mitchell; C N Metz; E F Morand
Journal:  Arthritis Rheum       Date:  2001-06

5.  An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.

Authors:  M Bacher; C N Metz; T Calandra; K Mayer; J Chesney; M Lohoff; D Gemsa; T Donnelly; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

6.  Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1.

Authors:  R Kleemann; A Hausser; G Geiger; R Mischke; A Burger-Kentischer; O Flieger; F J Johannes; T Roger; T Calandra; A Kapurniotu; M Grell; D Finkelmeier; H Brunner; J Bernhagen
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

7.  Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.

Authors:  Fabrizio De Benedetti; Cristina Meazza; Marina Vivarelli; Federica Rossi; Angela Pistorio; Rebecca Lamb; Mark Lunt; Wendy Thomson; Angelo Ravelli; Rachelle Donn; Alberto Martini
Journal:  Arthritis Rheum       Date:  2003-05

Review 8.  Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule.

Authors:  R P Donn; D W Ray
Journal:  J Endocrinol       Date:  2004-07       Impact factor: 4.286

9.  MIF as a glucocorticoid-induced modulator of cytokine production.

Authors:  T Calandra; J Bernhagen; C N Metz; L A Spiegel; M Bacher; T Donnelly; A Cerami; R Bucala
Journal:  Nature       Date:  1995-09-07       Impact factor: 49.962

10.  The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.

Authors:  H Y Lan; M Bacher; N Yang; W Mu; D J Nikolic-Paterson; C Metz; A Meinhardt; R Bucala; R C Atkins
Journal:  J Exp Med       Date:  1997-04-21       Impact factor: 14.307

View more
  16 in total

1.  MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome.

Authors:  Eva Cuzzoni; Raffaella Franca; Sara De Iudicibus; Annalisa Marcuzzi; Marianna Lucafò; Marco Pelin; Diego Favretto; Elena Monti; William Morello; Luciana Ghio; Claudio La Scola; Francesca Mencarelli; Andrea Pasini; Giovanni Montini; Giuliana Decorti; Gabriele Stocco
Journal:  Eur J Clin Pharmacol       Date:  2019-08-28       Impact factor: 2.953

2.  Polymorphisms of the MDR1 and MIF genes in children with nephrotic syndrome.

Authors:  Hyun Jin Choi; Hee Yeon Cho; Han Ro; So Hee Lee; Kyung Hee Han; Hyunkyung Lee; Hee Gyung Kang; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2011-05-08       Impact factor: 3.714

3.  Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in Turkish children with juvenile rheumatoid arthritis.

Authors:  Afig Berdeli; Arif Ruhi Ozyürek; Zülal Ulger; Dolunay Gürses; Ertürk Levent; Koray Salar; Ali Rahmi Gürpinar
Journal:  Rheumatol Int       Date:  2005-10-12       Impact factor: 2.631

Review 4.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

5.  A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.

Authors:  David N Assis; Hiroki Takahashi; Lin Leng; Mikio Zeniya; James L Boyer; Richard Bucala
Journal:  Dig Dis Sci       Date:  2016-10-01       Impact factor: 3.199

6.  Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.

Authors:  Timothy R D J Radstake; Jaap Fransen; Erik J M Toonen; Marieke J H Coenen; Agnes E Eijsbouts; Rachelle Donn; Frank H J van den Hoogen; Piet L C M van Riel
Journal:  Ann Rheum Dis       Date:  2007-04-24       Impact factor: 19.103

7.  The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors.

Authors:  Caroline Piette; Manuel Deprez; Thierry Roger; Agnès Noël; Jean-Michel Foidart; Carine Munaut
Journal:  J Biol Chem       Date:  2009-09-15       Impact factor: 5.157

8.  Association of the macrophage migration inhibitory factor -173*C allele with childhood nephrotic syndrome.

Authors:  Marina Vivarelli; Leila Emma D'Urbano; Gilda Stringini; Gian Marco Ghiggeri; Gianluca Caridi; Rachelle Donn; Alberto Tozzi; Francesco Emma; Fabrizio De Benedetti
Journal:  Pediatr Nephrol       Date:  2008-01-29       Impact factor: 3.714

Review 9.  A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease.

Authors:  Maria Tziastoudi; Georgios Pissas; Georgios Raptis; Christos Cholevas; Theodoros Eleftheriadis; Evangelia Dounousi; Ioannis Stefanidis; Theoharis C Theoharides
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

10.  New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus.

Authors:  Fang-Fang Wang; Li-An Zhu; Yu-Qiong Zou; Hui Zheng; Alisa Wilson; Cheng-De Yang; Nan Shen; Daniel J Wallace; Michael H Weisman; Shun-Le Chen; Liang-Jing Lu
Journal:  Arthritis Res Ther       Date:  2012-05-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.